Diphtheria, tetanus, pertussis and inactivated poliovirus vaccine (Boryung)

白喉/破伤风/百日咳/灭活脊髓灰质炎病毒疫苗

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria, tetanus, pertussis and inactivated poliovirus vaccine (Boryung)
Drug Alias NameDTaP-IPV combination vaccine (Boryung)Diphtheria-tetanus-acellular pertussisinactivated poliovirus vaccineBVN-002BR-8002
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Whole microorganism inactivated vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[4] 
Global Approved IndicationsPoliomyelitisTetanusDiphtheria +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2016/03/01
Country/TerritoryThailandSouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoryung Pharmaceutical Co Ltd
Inactive CompaniesBoryung Biopharma Co Ltd
Active IndicationsPoliomyelitisTetanusDiphtheria +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeJ07CA02
Related LinksWikipedia